Results for tag: "Male Urinary Incontinence"

The Male Urinary Incontinence market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat male urinary incontinence, a condition in which a person is unable to control their bladder and experiences involuntary leakage of urine. This condition is caused by a variety of factors, including age, prostate enlargement, neurological disorders, and certain medications. Treatment options for male urinary incontinence include lifestyle changes, medications, and surgery. The Male Urinary Incontinence market is highly competitive, with a variety of drugs available to treat the condition. These drugs are typically prescribed by urologists and other healthcare professionals. Commonly prescribed drugs include anticholinergics, alpha-blockers, and 5-alpha reductase inhibitors. Some companies in the Male Urinary Incontinence market include Pfizer, Astellas Pharma, Allergan, and Merck. Show Less Read more